For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Alex Zhavoronkov, founder & CEO of Insilico Medicine, stated that he “firmly believes that the repurposing of FDA-approved drugs with demonstrated anti-ageing potential represents a highly ...

The available drugs for Alzheimer’s could only temporarily ease some symptoms—not change anything about the underlying brain disease. But in just the past year and a half, two anti-amyloid ...

These NSAIDs (non-steroidal anti-inflammatory drugs) might help protect the brain ... March 21 (UPI) -- Parkinson's disease patients and advocates are marking Friday as the start of a new era ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

That’s according to a recent study by the universities of Cambridge and Exeter, where researchers evaluated several existing drugs to see ... wrote in the release. Anti-inflammatory medications ...

Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...

The herb rosemary has long been linked with memory. "There's rosemary, that's for remembrance," says Ophelia in Shakespeare's "Hamlet." So it is fitting that researchers would study a compound found ...